Keywords: fda, accepts, ndas, inkp-102, indiplon, zegrid, chewable

US FDA accepts NDAs for INKP-102, indiplon and Zegrid chewable tablets; OKs Ph I PV-10 trials

Article | 01 August 2005

The US Food and Drug Administration has accepted New Drug Application filings for: InKine Pharmaceutical's next-generation purgative agent INKP-102; Neurocrine's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Omeprazole

Prilosec

Go to drug listing